Clinical Interventions in Aging
Volume 9, 2014 - Issue
Open access
363
Views
39
CrossRef citations to date
0
Altmetric
Original Research
Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial
Alan G Wade1 CPS Research, Glasgow, UKCorrespondence[email protected]
, Mildred Farmer2 Meridien Research Inc., St Petersburg, FL, USA
, Gil Harari3 Medistat, Ltd, Tel Aviv, Israel
, Naama Fund3 Medistat, Ltd, Tel Aviv, Israel
, Moshe Laudon4 Neurim Pharmaceuticals Ltd, Tel Aviv, Israel
, Tali Nir4 Neurim Pharmaceuticals Ltd, Tel Aviv, Israel
, Anat Frydman-Marom4 Neurim Pharmaceuticals Ltd, Tel Aviv, Israel
& Nava Zisapel4 Neurim Pharmaceuticals Ltd, Tel Aviv, Israel;5 Department of Neurobiology, Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel
show all
Pages 947-961
|
Published online: 18 Jun 2014
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.